|
MAPK7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.884020E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.501900E-03 |
| Normal-vs-Stage2 |
5.114600E-01 |
| Normal-vs-Stage3 |
2.392800E-01 |
| Normal-vs-Stage4 |
1.629720E-02 |
| Stage1-vs-Stage2 |
1.799960E-01 |
| Stage1-vs-Stage3 |
1.964970E-01 |
| Stage1-vs-Stage4 |
7.064000E-01 |
| Stage2-vs-Stage3 |
7.076400E-01 |
| Stage2-vs-Stage4 |
1.420040E-01 |
| Stage3-vs-Stage4 |
1.882580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.456900E-03 |
| Normal-vs-AfricanAmerican |
1.182590E-01 |
| Normal-vs-Asian |
5.450000E-02 |
| Caucasian-vs-AfricanAmerican |
8.272200E-01 |
| Caucasian-vs-Asian |
8.117600E-01 |
| AfricanAmerican-vs-Asian |
9.708800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.983500E-02 |
| Normal-vs-Female |
1.940480E-02 |
| Male-vs-Female |
8.007600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.058900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.414000E-02 |
| Normal-vs-Age(61-80Yrs) |
4.821400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.800000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.847800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.959900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.609400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.524430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.558800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.499200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.090300E-02 |
| Classical-VS-Follicular |
2.6620927684462E-12 |
| Classical-VS-Other |
4.167800E-01 |
| Classical-VS-Normal |
2.646200E-04 |
| Tall-VS-Follicular |
9.382300E-03 |
| Tall-VS-Other |
9.399200E-01 |
| Tall-VS-Normal |
2.478600E-01 |
| Follicular-VS-Other |
1.534790E-01 |
| Follicular-VS-Normal |
6.792100E-02 |
| Other-VS-Normal |
4.829800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.064200E-01 |
| Normal-vs-N1 |
3.625600E-02 |
| N0-vs-N1 |
1.369960E-01 |
|
|
